Sponsor:
Cerenovus, Part of DePuy Synthes Products, Inc.
Code:
NCT06735833
Conditions
Migraine
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Not accepted
Interventions
Middle Meningeal Artery embolization
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-03-19. This information was provided to ClinicalTrials.gov by Cerenovus, Part of DePuy Synthes Products, Inc. on 2026-03-13.